Bone News and Research

RSS

Thalidomide improves remission in myeloma

Myeloma is one of the least curable cancers and involves plasma cells, the white blood cells that produce antibodies.

9 Mar 2006

Pregnancy diet has lifelong effects for baby

University of Nottingham researchers are targeting Europe's biggest killer diseases - by focusing on the diet of unborn babies.

8 Mar 2006

Scientists fight leukaemia with 'natural killer' cells

Scientists at the University of the West of England and the Bone Marrow Transplant Unit at the Bristol Children's Hospital have just won funding for a two-year project aimed at improving the outcome of bone marrow stem-cell transplants in young leukaemia patients.

8 Mar 2006

Cells used in bone marrow transplantation can develop into new cells lining the gut

The study showed that bone marrow derived cells can differentiate into functional gastrointestinal epithelial cells after bone marrow transplantation.

7 Mar 2006

Interferon-producing killer dendritic cell speeds up immune reactions and fights cancer

A mouse immune cell that plays dual roles as both assassin and messenger, normally the job of two separate cells, has been discovered by an international team of researchers from the United States and France.

7 Mar 2006

Orthopaedic medical device technologies that offer greater clinical benefits expected to succeed

Current users of medical device technologies for orthopaedic applications seek systems that offer maximum comfort while requiring minimum physical supervision. This is driving the market to continuously evolve technologies that use radically different approaches or make significant improvements to existing products.

6 Mar 2006

Mosquito virus kills 78 in a month - Indian ocean fears epidemic

While the rest of the world panics about bird flu, the islands of Mauritius, Reunion and the Seychelles in the Indian Ocean are in the grip of a mosquito-borne epidemic that has infected thousands and killed at least 78 in a month.

6 Mar 2006

Attaching new cytokine to neural stem cells derived from bone marrow kills brain tumor cells

Attaching a recently discovered cytokine to neural stem cells derived from bone marrow, researchers at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute have developed a tool to track and kill malignant brain tumor cells and provide long-term protection against their return.

1 Mar 2006

Bone marrow stem cells do not improve cardiac function in heart attack patients

There has been increasing evidence that stem cells contribute to regeneration of cardiac tissue and the development of new blood vessels following a heart attack, thus opening up new prospects for stem-cell based therapies.

1 Mar 2006

Scientists reprogramme malignant melanoma cells to become normal pigment cells

Scientists at Northwestern University and the Stowers Institute for Medical Research have reprogrammed malignant melanoma cells to become normal melanocytes, or pigment cells, a development that may hold promise in treating of one of the deadliest forms of cancer.

1 Mar 2006

$Hormone therapy for advanced prostate cancer can lead to bone loss and fractures$

Hormone therapy for advanced prostate cancer can lead to bone loss and fractures

A common type of treatment used to protect bone density in menopausal women is also an effective therapy for advanced prostate cancer patients during the first year of hormone therapy, according to a new Oregon Health & Science University Cancer Institute study.

1 Mar 2006

New findings on epoetin alfa for anemia

Mayo Clinic researchers working in concert with other North Central Cancer Treatment Group (NCCTG) investigators have found that administering epoetin alfa for anemia once every three weeks to patients with anemia and cancer, instead of the traditional weekly epoetin treatments, maintains similar levels of red blood cells.

1 Mar 2006

Girls drinking more sodas and less milk

According to researchers in the U.S. concerns that teens are drinking too many sodas and fruit drinks are well founded.

28 Feb 2006

Oral agent alendronate may help men with prostate cancer suffering from bone loss

Men with prostate cancer who experience bone loss from cancer treatment could benefit from a weekly oral therapy commonly given to women with osteoporosis, according to a study presented by the University of Pittsburgh Medical Center (UPMC) at the American Society of Clinical Oncology Prostate Cancer Symposium, Feb. 24 to 26 at the San Francisco Marriott.

27 Feb 2006

Bone News and Research

Thalidomide improves remission in myeloma

Pregnancy diet has lifelong effects for baby

Scientists fight leukaemia with 'natural killer' cells

Cells used in bone marrow transplantation can develop into new cells lining the gut

Interferon-producing killer dendritic cell speeds up immune reactions and fights cancer

Orthopaedic medical device technologies that offer greater clinical benefits expected to succeed

Mosquito virus kills 78 in a month - Indian ocean fears epidemic

Attaching new cytokine to neural stem cells derived from bone marrow kills brain tumor cells

Bone marrow stem cells do not improve cardiac function in heart attack patients

Scientists reprogramme malignant melanoma cells to become normal pigment cells

Hormone therapy for advanced prostate cancer can lead to bone loss and fractures

New findings on epoetin alfa for anemia

Girls drinking more sodas and less milk

Oral agent alendronate may help men with prostate cancer suffering from bone loss

Androgen deprivation therapy does not prevent prostate cancer from spreading

Study finds gene variant is no strong risk factor for osteoporosis

Low bone density improved with jabs twice a year

Selective T cell stimulation could help improve treatment of autoimmune disease and cancer

Atherosclerosis MAY be a result of bacteria from gum infection entering the bloodstream

Reovirus may be able to eliminate cancer cells from autologous stem cell transplants

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News